hypertrophic cardiomyopathyHCMnHCMoHCMMavacamten
…selective cardiac myosin inhibitor, is a therapeutic option for hypertrophic cardiomyopathy (HCM). Its impact on exercise capacity, health-related quality …
3articles mentioning diseases
6disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: oHCM ×
oHCM
This disease is selected. Its supporting articles are shown below.
Articles mentioning oHCM
3 articles · page 1 of 1oHCMsymptomatic obstructive hypertrophic cardiomyopathyMavacamtenSix-Minute Walk TestNICEBelfast Inherited Cardiac Services Centre
… the early real-world effectiveness and safety of mavacamten in oHCM, showing improvements in haemodynamics, biomarkers, and QoL met…
hypertrophic cardiomyopathyoHCMHCMMavacamtenNICESix-Minute Walk TestInherited Cardiac Services referral centreValsalva
…Introduction The treatment approach for hypertrophic cardiomyopathy (HCM) has advanced with the emergence of disease-specific thera…